Unclaimed brand
Developing best-in-class radiopharmaceuticals for cancer patients A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancers. Innovative Technologies Ratio Therapeutics’ Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack
Liking this brand profile? Share this page


Hex Code
Color name
RGB
HSL
CMYK
#005083
Orient
0, 80, 131
203, 100, 26
100, 39, 0, 49
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#035485
Venice Blue
3, 84, 133
203, 96, 27
98, 37, 0, 48
Ratio Therapeutics is a pharmaceutical company focused on developing targeted radiotherapeutics for people with cancer. Working from discovery through early clinical development, the company applies proprietary technologies to create small-molecule agents designed to reach a broad range of cancer targets. Its Trillium™ targeting scaffold combines pharmacokinetic modulation with chelation technology, supporting the development of compounds that can be paired with imaging or therapeutic radioisotopes. This “theranostic” approach allows a platform to support both imaging and treatment applications.
Ratio Therapeutics describes its platform as tunable and uses small-scale imaging trials in patients to help guide compound selection and reduce development risk. Its work is supported by an interdisciplinary team of scientists, engineers, and business professionals, alongside a network of researchers and clinicians. The company also highlights its intellectual property across multiple platform technologies, expertise in pharmacokinetic modulation, and two funded alliances with major pharmaceutical companies for first-in-human trials. Based in Boston, Ratio Therapeutics is dedicated to advancing radiopharmaceutical candidates for cancer care.
Company type
Privately Held
Year founded
2021
Company size
11-50 employees
Targeted radioligand therapy
Actinium-225 radiopharmaceuticals
Albumin-binding pharmacokinetic modulation
Macropa™ radiometal chelation
Theranostic drug development
How do I download the Ratio Therapeutics logo?
The Ratio Therapeutics logo comes in two versions: a logo and an icon. Download as transparent PNG or JPEG.
What does Ratio Therapeutics' branding look like?
The Ratio Therapeutics wordmark pairs a bold blue “Ratio” with smaller, bright-blue “THERAPEUTICS” lettering and a fine-line circular, looping motif that evokes a molecular or structural diagram. Its visual system combines clean, compact sans-serif typography and a white canvas with deep clinical blues, using vivid blue accents, scientific cell imagery, simple blue line icons, and spacious, orderly layouts.
What are Ratio Therapeutics' brand colors?
The Ratio Therapeutics color palette uses the hex codes #005083, #FFFFFF and #035485.
The Ratio Therapeutics name, logos and brand assets are trademarks of Ratio Therapeutics and its affiliates. Brandfetch isn't affiliated with or endorsed by Ratio Therapeutics. Their use is subject to Ratio Therapeutics's brand guidelines.